Odds ratio | 95% confidence limit | ||
---|---|---|---|
Age group | |||
66–69 years | 1.00 | ||
70–75 years | 1.01 | 1.00 | 1.02 |
Sex | |||
Male | 1.00 | ||
Female | 1.48 | 1.47 | 1.49 |
Race/ethnicity | |||
White | 1.00 | ||
Black | 0.78 | 0.77 | 0.80 |
Asian | 1.18 | 1.15 | 1.21 |
Hispanic | 1.12 | 1.09 | 1.15 |
Other | 1.07 | 1.05 | 1.09 |
Cohort Years | |||
2016 | 1.00 | ||
2017 | 1.12 | 1.12 | 1.13 |
2018 | 1.22 | 1.21 | 1.23 |
Regions | |||
Northeast | 1.00 | ||
Midwest | 0.98 | 0.97 | 0.99 |
South | 1.05 | 1.04 | 1.06 |
West | 1.12 | 1.10 | 1.13 |
Missing | 0.76 | 0.72 | 0.81 |
Payer Type | |||
Medicare only | 1.00 | ||
Dual Medicare/Medicaid | 0.80 | 0.79 | 0.81 |
Prevalent baseline comorbidity | |||
DM | 0.97 | 0.96 | 0.98 |
ASHD | 0.87 | 0.86 | 0.88 |
Heart failure | 0.79 | 0.78 | 0.81 |
CVA/TIA | 0.87 | 0.85 | 0.89 |
PVD | 0.95 | 0.94 | 0.97 |
Cardiac other | 1.09 | 1.07 | 1.10 |
Anemia | 1.01 | 1.00 | 1.02 |
Hypertension | 1.20 | 1.19 | 1.21 |
Hyperlipidemia | 1.42 | 1.41 | 1.43 |
CKD | 0.96 | 0.95 | 0.97 |
Cancer (nonskin) | 1.08 | 1.07 | 1.10 |
Liver disease | 1.04 | 1.01 | 1.07 |
COPD | 0.91 | 0.89 | 0.92 |
GI bleeding | 0.89 | 0.84 | 0.94 |